Editor: Faris Q.B. Alenzi

Molecular Targets and Cancer Therapeutics (Part 1)

eBook: US $89 Special Offer (PDF + Printed Copy): US $142
Printed Copy: US $98
Library License: US $356
ISBN: 978-981-5080-39-1 (Print)
ISBN: 978-981-5080-38-4 (Online)
Year of Publication: 2023
DOI: 10.2174/97898150803841230101

Introduction

Today, treatment options for cancer patients typically include surgery, radiation therapy, immunotherapy, and chemotherapy. While these therapies have saved lives and reduced pain and suffering, cancer still takes millions of lives every year around the world. Researchers are now developing advanced therapeutic strategies such as immunotherapy, targeted therapy, and combination nanotechnology for drug delivery. In addition, the identification of new biomarkers will potentiate early-stage diagnosis.

Molecular Targets and Cancer presents information about cancer diagnosis and therapy in a simple way. It covers several aspects of the topic with updated information on par with medical board levels. The book features contributions from experts and includes an overview of cancer from basic biology and pathology, classifications, surveillance, prevention, diagnosis, types of cancer, treatment and prognosis.

The first part of this book introduces the reader to cancer epidemiology, genetic alterations in cancer, exogenous and endogenous factors in carcinogenesis, roles for growth factors in cancer progression, cell signaling in cancer, transcription factors in cancer, and cancer genetics and epigenetics.

This comprehensive guide is a valuable resource for oncologists, researchers, and all medical professionals who work in cancer care and research.

Audience:

medical students, scientists, physicians and other healthcare professionals involved in cancer care and cancer research.